JP2024533998A5 - - Google Patents
Info
- Publication number
- JP2024533998A5 JP2024533998A5 JP2024508333A JP2024508333A JP2024533998A5 JP 2024533998 A5 JP2024533998 A5 JP 2024533998A5 JP 2024508333 A JP2024508333 A JP 2024508333A JP 2024508333 A JP2024508333 A JP 2024508333A JP 2024533998 A5 JP2024533998 A5 JP 2024533998A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- acid sequence
- colorectal cancer
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163231694P | 2021-08-10 | 2021-08-10 | |
| US63/231,694 | 2021-08-10 | ||
| PCT/US2022/074785 WO2023019186A2 (en) | 2021-08-10 | 2022-08-10 | Compositions and methods for treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533998A JP2024533998A (ja) | 2024-09-18 |
| JP2024533998A5 true JP2024533998A5 (https=) | 2025-08-20 |
Family
ID=85201061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508333A Pending JP2024533998A (ja) | 2021-08-10 | 2022-08-10 | 癌の治療のための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240360247A1 (https=) |
| EP (1) | EP4384220A4 (https=) |
| JP (1) | JP2024533998A (https=) |
| CN (1) | CN118139642A (https=) |
| AU (1) | AU2022326557A1 (https=) |
| CA (1) | CA3225489A1 (https=) |
| CL (1) | CL2024000370A1 (https=) |
| CO (1) | CO2024001405A2 (https=) |
| WO (1) | WO2023019186A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025171394A1 (en) * | 2024-02-09 | 2025-08-14 | The Johns Hopkins University | Compositions and methods for treatment of cancer |
| CN119861198B (zh) * | 2025-01-02 | 2025-09-16 | 哈尔滨脉图精准技术有限公司 | 用于区分早期肺癌与肺炎的血浆代谢标志物组合 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070085232A (ko) * | 2004-08-20 | 2007-08-27 | 더 존스 홉킨스 유니버시티 | 혈관신생 치료방법 |
| US11339213B2 (en) * | 2015-09-23 | 2022-05-24 | Mereo Biopharma 5, Inc. | Methods and compositions for treatment of cancer |
| PE20181326A1 (es) * | 2015-11-03 | 2018-08-20 | Janssen Biotech Inc | Anticuerpos que se unen especificamente a pd-1 y sus usos |
| US20200181264A1 (en) * | 2017-08-11 | 2020-06-11 | City Of Hope | Bispecific antigen-binding molecule |
| WO2019236722A1 (en) * | 2018-06-05 | 2019-12-12 | Chatterjee Subroto B | Inhibitors of glycosphingolipid synthesis and methods of use |
-
2022
- 2022-08-10 EP EP22856800.2A patent/EP4384220A4/en active Pending
- 2022-08-10 CA CA3225489A patent/CA3225489A1/en active Pending
- 2022-08-10 WO PCT/US2022/074785 patent/WO2023019186A2/en not_active Ceased
- 2022-08-10 CN CN202280068476.1A patent/CN118139642A/zh active Pending
- 2022-08-10 AU AU2022326557A patent/AU2022326557A1/en active Pending
- 2022-08-10 JP JP2024508333A patent/JP2024533998A/ja active Pending
-
2024
- 2024-02-06 CL CL2024000370A patent/CL2024000370A1/es unknown
- 2024-02-09 US US18/438,286 patent/US20240360247A1/en active Pending
- 2024-02-09 CO CONC2024/0001405A patent/CO2024001405A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4868698B2 (ja) | マクロファージが仲介する疾患の治療および診断 | |
| JP2024123124A (ja) | Ａｇｅ修飾細胞を除去するための、抗カルボキシメチルリシン抗体及び超音波 | |
| BRPI0709977A2 (pt) | uso de anticorpos de il-1 para o tratamento de distúrbios oftálmicos | |
| CN101415403A (zh) | 药物制剂的固体口服剂形式及其制备方法 | |
| CN102695722A (zh) | 对错误折叠的朊病毒蛋白具有特异性的抗体和表位 | |
| JP2024001125A (ja) | Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| JP2024533998A5 (https=) | ||
| JP2023549464A (ja) | Ｂ細胞免疫寛容の誘導及びｍＩｇＭ陽性発現Ｂ細胞リンパ腫の標的化における葉酸及び葉酸修飾の使用 | |
| KR102460465B1 (ko) | 알츠하이머병（ａｄ）의 치료 및 예방 | |
| WO2009103312A1 (en) | Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases | |
| EP2970503B1 (en) | Anti-(+) --methamphetamine monoclonal antibodies | |
| CN115702004A (zh) | 具有cd3和cd19双重特异性的聚乙二醇化t细胞衔接器 | |
| US20230027014A1 (en) | Therapeutic compositions comprising an amyloid beta antibody or vaccine for prevention and treatment of diastolic dysfunction | |
| KR102506460B1 (ko) | 알츠하이머병（ａｄ）의 치료 및 예방 | |
| JP7722989B2 (ja) | がんを治療するための方法及び組成物 | |
| Triplett et al. | Active immunization targeting amyloid β for the treatment of Alzheimer’s disease | |
| KR102388363B1 (ko) | 알츠하이머병（ａｄ）의 치료 및 예방 | |
| WO2022155499A1 (en) | Active delivery of radiotracers across the blood brain barrier | |
| RU2024106007A (ru) | Композиции и способы лечения злокачественного новобразования | |
| Ding et al. | PET imaging study of brown adipose tissue (BAT) activity in mice devoid of receptor for advanced glycation end products (RAGE) Yu-Shin Ding et al. | |
| JP2008540429A (ja) | 癌の治療における併用療法 | |
| Frank et al. | Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8+ T cell depletion | |
| Rogers et al. | O2–05–02: Alzheimer's disease drug discovery targeted to the APP MRNA 5'untranslated region, paroxetine and desferrioxamine proof‐of‐concept for a validated target | |
| Decourtb et al. | Active Immunization Targeting Amyloid β for the Treatment of AlzheimerLs | |
| WO2015165971A1 (en) | Treatment and prevention of alzheimer's disease (ad) |